Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Imugene Announces Outstanding Response Rates from the Phase 1b Trial of the Azer-cel Allogeneic CAR T in 3L+ DLBCL 2025-07-14 12:43
1